Rf value on tic was treated with mesyl chloride in pyridine to give the 6-0-mesyl derivative (7) . Mesylation of the other diastereomer showing higher Rf value was, however, unsuccessful recovering the starting material (6'). Treatment of 7 with sodium acetate in N,N-dimethylformamide (DMF) gave two products. The major one (8) In the next place, introduction of methyl groups to the 3-hydroxyl and 4-amino groups of the 4-N,3-O-didemethyl-2-deoxyfortamine portion is described. Treatment of 11 with sodium hydride in N,N-dimethylformamide gave a 4,5-cyclic carbamate derivative (13). This was indicated by the presence of an absorption peak at 1765 cm -1 in its IR spectrum. Since the relationship between the benzyloxycarbonylamino group at C-4 and the hydroxyl group at C-3 was trans-diaxial, the carbamate of 13 was assumed to be the 4,5-and not the 3,4-cyclic carbamate. Treatment of 13 with 2,2-dimethoxypropane in the presence of acidic catalyst gave a 4',6'-O-isopropylidene product (14). The compound 14 was then treated with a mixture of methyl iodide, barium oxide and barium hydroxide in N,N-dimethylformamide, when 4-N,3-O-dimethyl derivative (15) was produced in 67% yield.
Selective introduction of a methyl group at the C-4 amino group is described later (see the description of compound 19).
In the next place, introduction of an amino group at C-6' is described. Acidic solvolysis of 15 gave the diol (16). The compound 16 was treated with tosyl chloride to give the 6'-tosyl derivative (17). The tosyloxy group was then displaced with azido group. Selective hydrolysis of the cyclic carbamate yield. Finally, catalytic reduction of the azido group and hydrogenolysis of the protecting groups with palladium black gave the target product (21).
The synthesis of another target compound (27) will be described next.
Selective tosylation of 13 followed by substitution with sodium azide gave the 6'-azido compound glycyl group to the methylamino group at C-4 of 25 gave the condensation product (26) in 57 % yield.
Catalytic reduction and hydrogenolysis of 26 gave the deblocked title compound (27).
In the 'H-NMR spectrum of 21 (Fig. 3) , the resonance of H-4 (5.12 ppm) exhibited one large coupling (J3,4= 11.6 Hz). This indicates that the relationship between H-3 and H-4 is trans-diaxial. Judging from the above and the other 1H-NMR data, the cyclitol ring of 21 is in the 'C4 conformation in spite of the 4C, conformation of 12. This conformational inversion was also observed in the case of 27. These phenomena accord with the relationship between fortimicins A and B6~. Fig. 3 . 100 MHz 1H-NMR spectrum of 21 in D20. Medium: nutrient agar (Eiken Chemical Co., Ltd., Japan)
The minimal inhibitory concentrations of 21 and 27 are compared with those of sporaricin A in Table 1 . Antimicrobial activities of 21 and 27 were weaker than the activity of sporaricin A. The compound 27 showed similar activity to that of sporaricin A against Pseudomonas. We obtained 2-deoxyfortimicin B, the aminocyclitol of which was identical with those of 21 and 27 in N,O-situation and configuration, from the culture broth of Saccharopolyspora hirsuta subsp.
kobensis KC 6606, together with sporaricins A and B. On this subject we will report elsewhere.
Experimental
Thin-layer chromatography (tic) was carried out on E. Merck DC-Alufolien 60F254 with anisaldehyde-sulfuric acid spray for detection unless otherwise stated. --To a solution of 4 (2.1 g) and anhydrous p-toluenesulfonic acid (50 mg) in dry DMF (24 ml), 3,4-dihydro-2H-pyran (12 ml) was added and the solution was kept at room temperature for 3 hours. Usual work up gave the diastereoisomeric mixture 5 and 5' as a solid, 2.3 g (97 %), which as used without purification. 1,3,2'-Tris(N-benzyloxycarbonyl)-4',6'-O-isopropylidene-5-O-tetrahydropyranyllividamine(6 and 6') A solution of 5 (200 mg) in dry benzyl alcohol (4 ml) containing sodium benzylate (300 mg) was kept at room temperature for 20 hours under nitrogen. The reaction mixture showed, on tic with chloroform -methanol (15: 1), two marked spots at Rf 0.58 (6) and 0.69 (6', the diastereoisomer of 6). The solution was poured into water (200 ml) and resulting precipitates were dissolved in chloroform. The solution was washed with aqueous sodium chloride, dried (Na2SO4), and concentrated. The residue was chromatographed on a column of silica gel with chloroform -methanol (100: 1) to give 6 as a solid, 67.0 mg (29 %) and 6' as a solid, 69.2 mg (30 %). To an ice cold solution of 6 (680 mg) in dry pyridine (10 ml), methanesulfonyl chloride (300 mg) was added and the mixture was kept at room temperature for 1 hour. Aqueous sodium hydrogen carbonate was added and the mixture was extracted with chloroform. The solution was washed with water and aqueous sodium chloride, dried (Na2SO4), and concentrated to give a syrup, which was chromatographed on a column of silica gel with chloroform -methanol (100: 1) to give 7 as a solid, 580 mg (78%) 01 g ) in dry DMF (27 ml), sodium acetate (2.7 g) was added and the mixture was stirred at 100°C for I hour, then at 120°C for 2 hours. On tlc with chloroform -ethyl acetate (2: 1), the reaction mixture showed two marked spots at Rf 0.55 (8) and 0.46 (9) and some minor ones. The mixture was concentrated to a syrup. After addition of water, the mixture was extracted with chloroform. The solution was washed with aqueous sodium chloride, dried (Na2SO4), and concentrated to give a syrup. The syrup was chromatographed on a column of silica gel with chloroformethyl acetate (5: 1). Compounds 8 and 9 were eluted in this order to give a solid 520 mg (54%) and a solid 185 mg (19%), respectively. A solution of 8 (520 mg) in methanol containing 5 % ammonia (10 ml) was kept at room temperature for 2 hours and then concentrated. The residue was dissolved in a mixture of acetone -acetic acidwater (2: 9: 1, 24 ml). The solution was kept at 70'C for 3 hours and then concentrated. The residue was chromatographed on a column of silica gel with chloroform -methanol (20: 1) to give 11 as a solid, 322 mg (76%); [x]23D +30' (c 0.5, DMF).
Found: C, 60.69; H, 6.02: N, 5.68%. Calcd for C36H43N3O12: C, 60.92; H, 6.11; N, 5.92% 4-N,3-O-Didemethyl-2-deoxyfortamine (12) A solution of 11 (120 mg) in 5.5 N methanolic HCI (6 ml) was heated in a sealed tube at 80°C for 8 hours. Concentration followed by co-evaporation with water gave a residue. The solution of the residue in aqueous acetic acid (1: 2, 3 ml) was hydrogenated with palladium black. The reaction mixture was filtered and the filtrate was evaporated to give a solid, which was chromatographed on a column To an ice cold solution of 14 (100 mg) in dry DMF (2 ml), methyl iodide (2 ml), barium oxide (200 mg) and barium hydroxide monohydrate (250 mg) were added and the mixture was stirred in the dark in the cold for 5 minutes and then at room temperature for 1 hour. Additional aliquot (50 mg) of barium hydroxide monohydrate was added and the mixture was stirred for further 1 hour. Chloroform was added, the mixture was filtered, and the filtrate was evaporated to give a syrup, which was chromatographed on a column of silica gel with chloroform -methanol To a solution of 17 (220 mg) in dry DMF (5 ml), sodium azide (220 mg) was added and the mixture was stirred at 60°C for 10 hours. The mixture was concentrated, and the residue was dissolved in chloroform. The solution was washed with aqueous sodium chloride, dried (Na,SO,), and concentrated to give a syrup. It was chromatographed on a column of silica gel with chloroform -methanol 
